Risperidone Mesylate
| Code | Size | Price |
|---|
| TAR-T0351L-5mg | 5mg | £850.00 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here. | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Quantity:
Prices exclude any Taxes / VAT
Overview
Regulatory Status: RUO
Shipping:
cool pack
Storage:
-20℃
Documents
Further Information
Bioactivity:
Risperidone Mesylate is a selective serotonin 5-HT2 receptor and dopamine D2 receptor blocker.
CAS:
666179-96-0
Formula:
C24H31FN4O5S
Molecular Weight:
506.59
Purity:
0.98
SMILES:
CS(O)(=O)=O.Cc1nc2CCCCn2c(=O)c1CCN1CCC(CC1)c1noc2cc(F)ccc12
References
1. Termine C, Selvini C, Rossi G, Balottin U. Emerging treatment strategies in Tourette syndrome: what's in the pipeline? Int Rev Neurobiol. 2013;112:445-80. doi: 10.1016/B978-0-12-411546-0.00015-9. Review. PubMed PMID: 24295630.
2. Greenberg WM, Citrome L. Ziprasidone for schizophrenia and bipolar disorder: a review of the clinical trials. CNS Drug Rev. 2007 Summer;13(2):137-77. Review. PubMed PMID: 17627670.
3. Bayes M, Rabasseda X, Prous JR. Gateways to clinical trials. Methods Find Exp Clin Pharmacol. 2006 Mar;28(2):121-42. PubMed PMID: 16636723.
4. SMR Committee. Case histories in drug discovery and design. Drug News Perspect. 1998 Feb;11(1):52-7. PubMed PMID: 15616642.